This trend continues to grow, despite opioid harm reduction strategies such as medication formulations that decrease methods of abuse, education initiatives (such as www.AwareRX.org, founded in Minnesota), public medication take-back events, proper prescribing initiatives, and state-run Prescription Drug Monitoring Programs. When these efforts fail to prevent an overdose, a proven avenue to reduce morbidity and mortality is the use of naloxone, a pure opioid antagonist. Injectable naloxone has been available in the US for more than 40 years and is a standard rescue medication carried by emergency medical services (EMS). Some EMS programs have further developed a system to administer the injectable formulation intranasally via a marketed atomizer/nebulizer device, thereby decreasing concerns of transferring blood borne pathogens. 2 Rescue strategies are needed that reach beyond emergency response systems, thus becoming more accessible to the general public. Although programs of distribution continue to expand across the country, nineteen (76.0%) of the 25 states with 2008 drug overdose death rates higher than the median and nine (69.2%) of the 13 states in the highest quartile did not have a community-based opioid overdose prevention program that distributed naloxone. 3 Proper education and training is essential as the potential benefits of naloxone are temporary;
consequently, all users are instructed to call for emergency assistance as part of standard protocols. As highlighted in a recent article by Bailey et. al., community-based pharmacy practitioners have worked toward overcoming logistic and cultural barriers to make naloxone distribution for overdose a standard and acceptable practice. 4 Despite the increased recognition to improve access, some safety and ethical concerns have been raised in previous debates on expanded use of the medication. Health professionals have noted fatalities may result, especially if used by untrained people, and perhaps naloxone use may increase avoidance of contacting EMS. 4 -6 Though due to naloxone's short-half life, it is critical to receive additional medical services after the antidote is administered as further "reversal" may be warranted. 6 Another major obstacle has been that many states do not include naloxone as part "Good Samaritan" regulations protecting against legal implications when tending to persons in need of emergency aid. Pros and cons exist for an OTC naloxone. Impact from an OTC version will greatly increase the availability of naloxone; therefore, possibly saving thousands of lives if used correctly.
Conversely, misuse of the product could result in deaths through lack of patient education and failure to contact EMS. Pharmacists play a critical role in the appropriate use of nonprescription medications in self-care and this may be an optimal product to be considered with the Nonprescription Safe Use Regulatory Expansion (NSURE) Initiative requiring a consult with the pharmacist prior to sale. 
